Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Lupin launches generic antibiotic inhalation solution in US

      Lupin launches generic antibiotic inhalation solution in US

      Ruby Khatun Khatun15 Jun 2018 10:30 AM IST
      New Delhi: Drug firm Lupin said it has launched its antibiotic Tobramycin inhalation solution in the US market.The company has launched the product as...
      OmniVision introduces smallest HD medical image sensor for endoscopes and catheters

      OmniVision introduces smallest HD medical image sensor for endoscopes and catheters

      Ruby Khatun Khatun15 Jun 2018 10:15 AM IST
      SANTA CLARA: OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions announced from MD&M East in NYC the OH01A,...
      Johnson and Johnson accepts 2.1 billion dollar offer for its LifeScan unit

      Johnson and Johnson accepts 2.1 billion dollar offer for its LifeScan unit

      Ruby Khatun Khatun15 Jun 2018 9:30 AM IST
      Johnson and Johnson said on Tuesday it has accepted private equity firm Platinum Equity’s $2.1 billion buyout offer for the company’s LifeScan Inc...
      NPPA fixes prices of 22 drugs including ORS, Sun pharmas Rosuvas, Details

      NPPA fixes prices of 22 drugs including ORS, Sun pharmas Rosuvas, Details

      Ruby Khatun Khatun14 Jun 2018 5:10 PM IST
      New Delhi: The national drug pricing regulator NPPA has fixed the retail and ceiling prices of 22 formulations used for the treatment of various...
      Fortis Healthcare pulls out of amalgamation scheme with Fortis Malar, SRL

      Fortis Healthcare pulls out of amalgamation scheme with Fortis Malar, SRL

      Ruby Khatun Khatun14 Jun 2018 4:26 PM IST
      Fortis Healthcare Ltd on Wednesday withdrew the scheme of arrangement and amalgamation with its units Fortis Malar Hospitals Ltd and SRL Ltd, citing a...
      Ways to Protect Your Family from Killer Illnesses in a Metro City

      Ways to Protect Your Family from Killer Illnesses in a Metro City

      Ruby Khatun Khatun14 Jun 2018 12:14 PM IST
      With the rapid urbanization taking place in India, on the one hand, we can avail the best of technologies and lifestyle, but on the other hand, we are...
      NirogStreet raises Rs 2 crore from Spiral Ventures

      NirogStreet raises Rs 2 crore from Spiral Ventures

      Ruby Khatun Khatun14 Jun 2018 10:00 AM IST
      New Delhi: India's first technology-led Ayurveda platform, NirogStreet on Wednesday announced raising USD 300k (Rs 2 crore) from the Japanese venture...
      Medical device maker Stryker says not in talks to buy Boston Scientific

      Medical device maker Stryker says not in talks to buy Boston Scientific

      Ruby Khatun Khatun14 Jun 2018 10:00 AM IST
      Medical device maker Stryker Corp is not in talks to buy rival Boston Scientific Corp, the company said in a regulatory filing on Wednesday, two days...
      Lilly-AstraZeneca latest to abandon Alzheimers drug trials

      Lilly-AstraZeneca latest to abandon Alzheimer's drug trials

      Ruby Khatun Khatun14 Jun 2018 9:45 AM IST
      Eli Lilly and Co and AstraZeneca Plc said on Tuesday they would discontinue late-stage trials testing their Alzheimer’s treatment, the latest among a...
      EU endorses new measures to protect women from valproate epilepsy drug

      EU endorses new measures to protect women from valproate epilepsy drug

      Ruby Khatun Khatun14 Jun 2018 9:30 AM IST
      PARIS: French regulator ANSM said epilepsy drug valproate would face new restrictions across the European Union to protect pregnant women or of...
      Seperate, Visible Shelf For GENERIC Medicines at Every Chemist: Health Ministry New order

      Seperate, Visible Shelf For GENERIC Medicines at Every Chemist: Health Ministry New order

      Ruby Khatun Khatun13 Jun 2018 4:08 PM IST
      New Delhi: To increase the affordability of generic medicines and to provide low-cost benefits to consumers, the government has made it compulsory for...
      Sun Pharma gets clearance for Halol plant from USFDA

      Sun Pharma gets clearance for Halol plant from USFDA

      Ruby Khatun Khatun13 Jun 2018 11:57 AM IST
      Mumbai: Supply restrictions imposed on India’s largest drugmaker Sun Pharmaceutical Industries by U.S. regulators have been lifted, the company said...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok